Company Presentation • 11 May 2026 19:00
Company Presentation • 20 Apr 2026 19:00
Company Presentation • 09 Mar 2026 19:00
Company Presentation • 03 Nov 2025 20:00
Company Presentation • 14 Sep 2024 00:00
No more presentations
𝛼SK or SearchENTITY
Prelude Therapeutics (PRLD US)
Prelude Therapeutics (PRLD US)
2
Analysis
Health Care • United States
Prelude Therapeutics Incorporated operates as a biopharmaceutical company. The Company develops and designs a pipeline of novel, orally bioavailable, and small molecule therapies that target key drivers of cancer cell growth. Prelude Therapeutics serves patients worldwide.
morex